Thrombin generation test – As a potential marker of severity and outcome of severe pneumonia with pulmonary sepsis

T. Martynenko, I. Balatskaya, S. Yakov, M. Aleksey, O. Rusakova, A. Grebenyuk (Barnaul, Russian Federation)

Source: Annual Congress 2012 - Respiratory infections: prognosis and outcome
Session: Respiratory infections: prognosis and outcome
Session type: Thematic Poster Session
Number: 2482

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Martynenko, I. Balatskaya, S. Yakov, M. Aleksey, O. Rusakova, A. Grebenyuk (Barnaul, Russian Federation). Thrombin generation test – As a potential marker of severity and outcome of severe pneumonia with pulmonary sepsis. Eur Respir J 2012; 40: Suppl. 56, 2482

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Procalcitonin and clinical pulmonary infection score as predictors of stroke associated pneumonia.
Source: International Congress 2018 – Critically ill patients: prognostic factors and biomarkers
Year: 2018

The correlation between D-dimer and pneumonia severity in H1N1 patients
Source: Annual Congress 2010 - Influenza A (H1N1): characteristics, risk factors and prognosis
Year: 2010

Pneumococcal pneumonia – Are the new severity scores more accurate in predicting adverse outcomes?
Source: Annual Congress 2011 - Aetiology, diagnosis and outcomes in community-acquired pneumonia
Year: 2011


Clinical pulmonary infection score (CPIS) and inflammatory response in patients with new pulmonary infiltrates and suspected ventilator acquired pneumonia (VAP)
Source: Annual Congress 2005 - Diagnosis and prognosis of ventilator associated pneumonia: the clinical track
Year: 2005


Prognostic value of pulmonary function testing in idiopathic pulmonary hypertension – The most relevant differences between survivors and non-survivors in three-years observation study
Source: Annual Congress 2012 - Pulmonary circulation: clinical end-points and clinical physiology
Year: 2012

Eosinopenia in COPD patients with severe acute respiratory virus 2 (Sars-CoV-2) infection as a potential fatal outcome predictor
Source: Virtual Congress 2021 – COVID-19 and obstructive diseases: risk factors, management and long-term effects
Year: 2021


Performance of rapid, bedside whole blood C-reactive protein (CRP) test as a diagnostic test for bacterial infection and pneumonia in patients with acute exacerbation of chronic obstructive pulmonary disease (AE COPD)
Source: Eur Respir J 2007; 30: Suppl. 51, 557s
Year: 2007

Copeptin application in severe community-acquired pneumonia (SCAP) severity assessment and outcomes
Source: Annual Congress 2012 - Respiratory infections: a clinical point of view
Year: 2012


Procalcitonin and neopterin in community-acquired pneumonia – correlation with microbial aetiology, severity and mortality
Source: Annual Congress 2009 - Assessment of severity in respiratory infections: severity scales and biomarkers
Year: 2009

Role of biomarkers of systemic inflammation in the prediction of mortality and/or severe complications in community adquired pneumonia
Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia
Year: 2019


D-dimer elevation is associated with severity of community-acquired pneumonia according to CURB-65 and PSI
Source: Annual Congress 2006 - Inflammation markers in community-acquired pneumonia
Year: 2006


Usefulness of admission red cell distribution Width as a predictor of early mortality in patients with severe exacerbation of chronic obstructive pulmonary disease
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013

Is it connection between systemic inflammation and risk of thrombotic disorders (by Padua scale) in hospitalized patients with community-acquired pneumonia (CAP)?
Source: International Congress 2018 – Predicting the future: biomarkers of respiratory infection
Year: 2018

Endothelial dysfunction and prognostic significance of endothelin-1 in patients with severe pneumonia and pulmonary sepsis
Source: International Congress 2015 – Immunodepression and severe pneumonia
Year: 2015

Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome
Source: Eur Respir J 2011; 37: 356
Year: 2011



Thrombotic disorders (blood coagulation test and Padua Prediction Score for risk of lung thrombosis)in hospitalized patients with community-acquired pneumonia (CAP)
Source: International Congress 2018 – Predicting the future: biomarkers of respiratory infection
Year: 2018


Analysis of prevalence of depression in patients with tuberculosis and pneumonia – Is depression consequance only in chronic clinical failure ?
Source: Annual Congress 2010 - The psychological impact and educational issues of chronic lung disease: could we do more?
Year: 2010

Acute respiratory distress syndrome (ARDS) – Manifestation of onset in an immunocompetent patient with pleuropulmonary tuberculosis (TB)
Source: Annual Congress 2012 - Viral infections and rare respiratory infections
Year: 2012

Systemic cytokine levels in community-acquired pneumonia and their association with disease severity
Source: Eur Respir J 2002; 20: 990-995
Year: 2002



Outcome analysis of ‘do not resuscitate‘ versus ‘full resuscitation‘ patients with an acute exacerbation of COPD treated with noninvasive ventilation in a pulmonary unit
Source: Annual Congress 2011 - Recent advances in noninvasive ventilation used for treating acute respiratory failure
Year: 2011